Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zemiglo in Type 2 Diabetes Mellitus
NCT01601990Phase 3Completed
- Sponsor
- LG Chem
- Start
- Dec 2009
- Primary completion
- Mar 2011
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of glimepiride in type 2 diabetes mellitus (T2DM), sponsored by LG Chem. Started Dec 2009; status: completed.
02
Drugs
glimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01601990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601990.